Appointments will be scheduled by calling Lincoln County Health Department at 704-735-3001.
October 27, 2021
COVID-19 VACCINE APPOINTMENT UPDATE – LINCOLN COUNTY, NC
Lincolnton, NC – In light of changes in FDA COVID-19 vaccine guidance and demand for third and booster doses of the COVID-19 vaccine, appointments will be scheduled by calling Lincoln County Health Department at 704-735-3001.
For individuals who received a Moderna or Pfizer COVID-19 vaccine, the following groups may receive a booster shot (lower dose) no earlier than 6 months after completion of their initial series:
65 years and older
Age 18+ who live in long-term care settings
Age 18+ who have underlying medical conditions
Age 18+ who work or live in high-risk settings
Individuals who received the Johnson & Johnson COVID-19 vaccine, booster shots are recommended for those who are 18 and older and were vaccinated two or more months ago. A COVID-19 mRNA vaccine may also be given as a booster shot to these individuals.
A third full dose of mRNA COVID-19 (Pfizer or Moderna) vaccine is recommended for moderately and severely immunocompromised people. This priority group consists of patients who self-attest to being moderately to severely immunocompromised. The CDC defines this as those who have:
• Been receiving active cancer treatment for tumors or cancers of the blood
• Received an organ transplant and are taking medicine to suppress the immune system
• Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
• Moderate or severe primary immunodeficiency (such as DiGeorge syndrome)
• Advanced or untreated HIV infection
• Active treatment with medication that may suppress your immune response
If a person received the Pfizer or Moderna series, they can receive either Pfizer or Moderna for the third dose. The third dose does not have to be the same manufacturer as the initial series. The third dose for moderately and severely immunocompromised people shall be administered at least 28 days after completion of the initial 2-dose vaccine series.